World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
62
Citations
16804
World Ranking
10642
National Ranking
813

Jane A. Endicott publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Jane A. Endicott sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 225 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Jane A. Endicott D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Jane A. Endicott sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 62 D-Index — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Enzyme
  • Biochemistry

Her main research concerns Biochemistry, Cyclin-dependent kinase, Kinase, Cyclin-dependent kinase 2 and Cyclin-dependent kinase 1. In the subject of general Biochemistry, her work in Cyclin-dependent kinase complex, Glycoprotein, Phosphorylation and Histone H3 is often linked to P-glycoprotein, thereby combining diverse domains of study. The Cyclin-dependent kinase study which covers Cyclin that intersects with Cyclin-dependent kinase 5.

Her Kinase study improves the overall literature in Cell biology. Her Cyclin-dependent kinase 2 research incorporates themes from Protein structure and Stereochemistry. Her Cyclin-dependent kinase 1 research incorporates elements of Molecular biology and Cell growth.

Her most cited work include:

  • The biochemistry of P-glycoprotein-mediated multidrug resistance. (1811 citations)
  • Protein kinase inhibitors: insights into drug design from structure. (1021 citations)
  • Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. (642 citations)

What are the main themes of her work throughout her whole career to date?

Jane A. Endicott spends much of her time researching Cyclin-dependent kinase, Cell biology, Cyclin-dependent kinase 2, Biochemistry and Kinase. Jane A. Endicott combines subjects such as Cyclin-dependent kinase 1, Binding site and Cyclin with her study of Cyclin-dependent kinase. The study incorporates disciplines such as Cancer research and Purine in addition to Cyclin-dependent kinase 1.

Her work deals with themes such as Protein structure, Cell cycle, Ubiquitin and Cyclin D, which intersect with Cell biology. She interconnects Stereochemistry and Mitogen-activated protein kinase kinase in the investigation of issues within Cyclin-dependent kinase 2. Her studies examine the connections between Kinase and genetics, as well as such issues in Computational biology, with regards to Drug discovery.

She most often published in these fields:

  • Cyclin-dependent kinase (37.01%)
  • Cell biology (36.36%)
  • Cyclin-dependent kinase 2 (30.52%)

What were the highlights of her more recent work (between 2013-2021)?

  • Cell biology (36.36%)
  • Cyclin-dependent kinase (37.01%)
  • Cyclin-dependent kinase 1 (15.58%)

In recent papers she was focusing on the following fields of study:

Jane A. Endicott mainly investigates Cell biology, Cyclin-dependent kinase, Cyclin-dependent kinase 1, Cyclin-dependent kinase 2 and Kinase. The concepts of her Cell biology study are interwoven with issues in Genetics, Structural motif, Mutant and Nuclear transport. Her Cyclin-dependent kinase study combines topics from a wide range of disciplines, such as Binding site and Cyclin.

Her Cyclin study incorporates themes from Computational biology and Protein kinase A. Her Cyclin-dependent kinase 2 research includes themes of Cancer research and Stereochemistry. Her Kinase study is concerned with Biochemistry in general.

Between 2013 and 2021, her most popular works were:

  • CDK1 structures reveal conserved and unique features of the essential cell cycle CDK. (83 citations)
  • CDK1 structures reveal conserved and unique features of the essential cell cycle CDK. (83 citations)
  • Structural insights into the functional diversity of the CDK–cyclin family (49 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Genetics

Jane A. Endicott mainly focuses on Cyclin-dependent kinase, Cell biology, Binding site, Cell cycle and Cyclin-dependent kinase 1. Her study in Kinase extends to Cyclin-dependent kinase with its themes. Her Kinase research includes elements of Apoptosis, Transcription and Cyclin.

Her studies deal with areas such as Nuclear transport, Cell nucleus, Importin, Nuclear protein and Ankyrin repeat as well as Cell biology. Her Binding site research integrates issues from Adenosine triphosphate, Druggability, Pharmacophore, Stereochemistry and Structure–activity relationship. Her Cyclin-dependent kinase 1 research focuses on Cyclin-dependent kinase 2 and how it relates to Conformational energy, Non-competitive inhibition and Transferase.

Best Publications

  • The biochemistry of P-glycoprotein-mediated multidrug resistance.

    Endicott Ja;Ling

  • Protein kinase inhibitors: insights into drug design from structure.

    Martin E. M. Noble;Jane A. Endicott;Louise N. Johnson

  • Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.

    Ralph Hoessel;Sophie Leclerc;Jane A. Endicott;Martin E. M. Nobel

  • Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance

    James H. Gerlach;Jane A. Endicott;Peter F. Juranka;Graham Henderson;Graham Henderson

  • The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases

    Nick R. Brown;Martin E. M. Noble;Jane A. Endicott;Louise N. Johnson

  • The Structural Basis for Control of Eukaryotic Protein Kinases

    Jane A. Endicott;Martin E.M. Noble;Louise N. Johnson

  • Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2

    Alison M. Lawrie;Martin E.M. Noble;Paul Tunnah;Nicholas R. Brown

  • Molecular Basis for the Recognition of Phosphorylated and Phosphoacetylated Histone H3 by 14-3-3

    Neil Macdonald;Julie P.I. Welburn;Martin E.M. Noble;Anhco Nguyen

  • Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor

    T.G Davies;J Bentley;C.E Arris;F.T Boyle

  • Effects of Phosphorylation of Threonine 160 on Cyclin-dependent Kinase 2 Structure and Activity

    Nicholas R. Brown;Martin E.M. Noble;Alison M. Lawrie;May C. Morris

  • Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumor Cell Growth Inhibition Profiles.

    C.E Arris;F.T Boyle;A.H Calvert;N.J Curtin

  • The crystal structure of cyclin A

    NR Brown;Mem Noble;JA Endicott;EF Garman

  • CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases

    K Bettayeb;N Oumata;A Echalier;Y Ferandin

  • Inhibitor Binding to Active and Inactive CDK2: The Crystal Structure of CDK2-Cyclin A/Indirubin-5-Sulphonate

    Thomas G. Davies;Paul Tunnah;Laurent Meijer;Doris Marko

  • Structural insights into the functional diversity of the CDK–cyclin family

    Daniel J. Wood;Jane A. Endicott

  • Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects.

    Yvette Mettey;Marie Gompel;Virginie Thomas;Matthieu Garnier

  • CDK1 structures reveal conserved and unique features of the essential cell cycle CDK.

    Nicholas R. Brown;Nicholas R. Brown;Svitlana Korolchuk;Mathew P. Martin;Will A. Stanley

  • Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex.

    Aude Echalier;Karima Bettayeb;Yoan Ferandin;Olivier Lozach

  • Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.

    M Lu;H Breyssens;V Salter;S Zhong

  • The structural basis for control by phosphorylation

    Mem Noble;JA Endicott;LN Johnson;NR Brown

Frequent Co-Authors

Martin E.M. Noble
Martin E.M. Noble Newcastle University
Louise N. Johnson
Louise N. Johnson University of Oxford
Bernard T. Golding
Bernard T. Golding Newcastle University
Nicola J. Curtin
Nicola J. Curtin Newcastle University
Laurent Meijer
Laurent Meijer Perha Pharmaceuticals
Christian Doerig
Christian Doerig RMIT University
Victor Ling
Victor Ling BC Cancer Research Centre
Elspeth F. Garman
Elspeth F. Garman University of Oxford
Peter M. Fischer
Peter M. Fischer University of Nottingham
Stefan T. Arold
Stefan T. Arold King Abdullah University of Science and Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Jane A. Endicott

Trending Scientists

Recently Published Articles